REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JACOB LALEZARI, Quest Clinical Research, San Francisco
Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of Quest Clinical Research in San Francisco. He presented 48 week results from the MOTIVATE 1 study and Derek Thorne spoke to him at ICAAC in Chicago.
HOWARD MAYER, Pfizer Global Research, New London CT
MARK WAINBERG, McGill University, Montreal
Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and
Catherine Demers
Recombinent human growth hormone has achieved clinical responses when used for treating heart failure. Catherine Demers of McMaster University
[...] 48 week results from the MOTIVATE 1 study and Derek Thorne spoke to him …Original post by admin delivered by Medtrials and [...]